Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
28 hedge funds and large institutions have $1.33M invested in Biotricity, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
12% more capital invested
Capital invested by funds: $1.19M → $1.33M (+$142K)
3% less funds holding
Funds holding: 29 → 28 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$68.5K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$52.7K |
| 3 |
ARC
Advisor Resource Council
Dallas,
Texas
|
+$20.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.7K |
| 5 |
VF
Virtu Financial
New York
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$14.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.08K |
| 3 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$5.52K |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$894 |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
-$403 |
BTCY Hedge Fund Activity: Q1 2023 in Review
28 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q1 2023, worth a combined $1.33M — up 12% from $1.19M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BTCY and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 7 added.
The largest buyer was AE Wealth Management, adding an estimated $68.5K. The largest seller was Jane Street, exiting entirely with an estimated $14.9K sold.
- 28 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q1 2023, down from 29 in Q4 2022.
- Funds reported $1.33M of Biotricity, Inc. Common Stock stock for Q1 2023, up 12% quarter-over-quarter.
- 5 funds opened new Biotricity, Inc. Common Stock positions in Q1 2023 and 6 closed out, a net change of -1 holder.
- The largest Biotricity, Inc. Common Stock buyer in Q1 2023 was AE Wealth Management, an estimated $68.5K added.
- The largest Biotricity, Inc. Common Stock seller in Q1 2023 was Jane Street, an estimated $14.9K sold.
Based on aggregated 13F filings for Q1 2023.